HCW Biologics Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

HCW Biologics Inc. reported Cash And Cash Equivalents At Carrying Value of $1.95 million for the year ending 2025.

  • HCW Biologics Inc. showed a decrease of -58.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
  • This data is from HCW Biologics Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
  • XBRL data for this metric is available from 2019 to 2025 (7 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 7 years of available data (2019 to 2025), HCW Biologics Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 73.5%.
  • Historical annual values: Fiscal year 2025: $1.95 million | Fiscal year 2024: $4.67 million | Fiscal year 2023: $3.60 million | Fiscal year 2022: $22.33 million | Fiscal year 2021: $11.73 million | Fiscal year 2020: $8.46 million | Fiscal year 2019: $7.36 million.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: